CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 6, 2017--
WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company
focused on developing targeted therapies for patients impacted by rare
diseases, today announced that Paul Bolno, M.D., MBA, President and
Chief Executive Officer, will be participating at the following upcoming
Jefferies 2017 Global Healthcare Conference – WAVE Company Presentation
June 7th at 1:30 P.M. ET – New York
The JMP Securities Life Science Conference – Company Panel Discussion:
Tuesday, June 20th at 2:00
P.M. ET – New York
A live webcast of the WAVE company presentation at the Jefferies 2017
Global Healthcare Conference will be available on the investor relations
page of the WAVE Life Sciences corporate website at http://ir.wavelifesciences.com.
A replay will remain archived on the corporate website for a limited
About WAVE Life Sciences
At WAVE Life Sciences, we are driven by an unwavering passion and
commitment to deliver on our mission of confronting challenging diseases
by developing transformational therapies and empowering patients. We are
utilizing our innovative and proprietary synthetic chemistry drug
development platform to design, develop and commercialize rationally
redesigned nucleic acid therapeutics that precisely target the
underlying cause of rare and other serious genetically defined diseases.
Given the versatility of our chemistry platform, WAVE’s deep, diverse
pipeline spans multiple modalities including antisense, exon-skipping,
and single-stranded RNAi. For more information, please visit www.wavelifesciences.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170606005594/en/
Source: WAVE Life Sciences Ltd.
Media and Investors:
WAVE Life Sciences